// App-Quantinova.ai

3558 : Predicting response to Mcl-1 targeting agents in NSCLC and multiple myeloma

Researchers

Presenter

  • Kristen McEachern

Principal Investigators

  • Greg OConnor

  • Justin Cidado

  • Matthew Belmonte

  • Evan Barry

  • Hannah Dry

  • Paul Secrist

  • Lisa Drew

Medical Centers

  • AstraZeneca, Waltham, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Hematological malignancies

  • Multiple Myeloma

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • Myeloid Cell Leukemia 1

  • B-cell lymphoma 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved